Health Net
Gilenya (fingolimod)
Drugs for the Nervous System : Drugs for Multiple Sclerosis
  • Quantity Limits Apply
  • Prior Authorization: Multiple Sclerosis (MS):
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Age Requirement: >= 10
    Duration: 1 plan year
    Reauthorization Required: Yes

  • I. Health Net Approved Indications and Usage Guidelines: A. Approved for relapsing remitting multiple sclerosis (RRMS) confirmed by a neurologist. II. Coverage is Not Authorized For: Primary progressive multiple sclerosis. III. Authorization Limit: Length of Benefit; For AHCS requests: One Year.
  • Multiple Sclerosis (MS):
    Age Requirement: >= 10
    Duration: 1 plan year
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Specialist Type(s): Neurologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Patients Cardiac Medical History Required: No
    Concomitant use of other MS medication: No
    Supporting Documentation Requirements: 3 of Chart Notes;Documentation of baseline number of relapses per year;Documentation of expanded disability status scale (EDSS) score;Lab Tests

  • Limited Access. Must use AcariaHealth Specialty Rx.